These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23506002)

  • 41. Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stress-deprived tendons: an in vitro experimental study.
    Arnoczky SP; Lavagnino M; Egerbacher M; Caballero O; Gardner K
    Am J Sports Med; 2007 May; 35(5):763-9. PubMed ID: 17293464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.
    Tommasi RA; Weiler S; McQuire LW; Rogel O; Chambers M; Clark K; Doughty J; Fang J; Ganu V; Grob J; Goldberg R; Goldstein R; Lavoie S; Kulathila R; Macchia W; Melton R; Springer C; Walker M; Zhang J; Zhu L; Shultz M
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6440-5. PubMed ID: 21937229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.
    Marcial BL; Sousa SF; Barbosa IL; Dos Santos HF; Ramos MJ
    J Phys Chem B; 2012 Nov; 116(46):13644-54. PubMed ID: 23121406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of cathepsin G: a patent review (2005 to present).
    Kosikowska P; Lesner A
    Expert Opin Ther Pat; 2013 Dec; 23(12):1611-24. PubMed ID: 24079661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boehringer Ingleheim's selective glucocorticoid receptor agonist development candidate: evaluation of WO2010141331, WO2010141332 and WO2010141333.
    Norman P
    Expert Opin Ther Pat; 2011 Jul; 21(7):1137-42. PubMed ID: 21548852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
    Zeldich E; Koren R; Dard M; Weinberg E; Weinreb M; Nemcovsky CE
    J Periodontal Res; 2010 Apr; 45(2):200-6. PubMed ID: 19909407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal agents, WO2009025733.
    Sudhir PV; Ranjan DS; Ganpat AN
    Expert Opin Ther Pat; 2010 Jan; 20(1):137-43. PubMed ID: 19874257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.
    Selivanova SV; Stellfeld T; Heinrich TK; Müller A; Krämer SD; Schubiger PA; Schibli R; Ametamey SM; Vos B; Meding J; Bauser M; Hütter J; Dinkelborg LM
    J Med Chem; 2013 Jun; 56(12):4912-20. PubMed ID: 23688254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes.
    Choi WY; Lim HW; Lim CJ
    J Pharm Pharmacol; 2013 Feb; 65(2):310-6. PubMed ID: 23278699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis.
    Xue M; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2007 Sep; 56(9):2864-74. PubMed ID: 17763449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel 1,5-naphthyridine PI3Kδ inhibitors, an evaluation of WO2011075628.
    Norman P
    Expert Opin Ther Pat; 2011 Nov; 21(11):1805-10. PubMed ID: 21939430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis].
    Yamanaka H
    Nihon Rinsho; 2002 Dec; 60(12):2325-30. PubMed ID: 12510357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis.
    Satish Kumar K; Velayutham R; Roy KK
    J Biomol Struct Dyn; 2020 Jul; 38(10):3074-3086. PubMed ID: 31378153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteinase-2 inhibition by temocapril and its important role in peritoneal transport.
    Yamamoto D; Takai S; Akimoto T; Hirahara I; Ito C; Muto S; Kusano E
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):864-8. PubMed ID: 23013132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MMPREDOX/NO interplay in periodontitis and its inhibition with Satureja hortensis L. essential oil.
    Zeidán-Chuliá F; Neves de Oliveira BH; Gursoy M; Könönen E; Fonseca Moreira JC; Gursoy UK; Uitto VJ
    Chem Biodivers; 2013 Apr; 10(4):507-23. PubMed ID: 23576339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent developments in CCR2 antagonists.
    Xia M; Sui Z
    Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent patents in the discovery of small molecule inhibitors of JAK3.
    Wilson LJ
    Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective MMP-12 inhibitors: WO-2008057254.
    Norman P
    Expert Opin Ther Pat; 2009 Jul; 19(7):1029-34. PubMed ID: 19456279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.